Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi

5-Hydroxytryptamine Receptor 6

  • Marcela Pereira
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-67199-4_101490

Synonyms

Historical Background

Up to date, there are 14 different subtypes of 5-HT receptors (5-HTR) discovered and they are divided into seven major classes (5-HT1 to 5-HT7). All these receptors are G protein-coupled receptors (GPCRs), except for 5-HT3 that is a part of the Cys-loop superfamily of ligand-gated ion channels (LGICs). 5-HT1 class (composed by 5 subtypes – 5-HT1a-f) is coupled with a Gi/o protein, which inhibits adenylate cyclase (AC) activity and modulates calcium and potassium channels; 5-HT2 class (composed by 3 subtypes – 5-HT2a-c) is coupled with a Gq protein, which activates the phospholipase C pathways and releases inositol triphosphate (IP3) and diacylglycerol (DAG). The last group is composed by 5-HT4 to 5HT7 receptors and they are all Gs coupled; therefore, their activation regulates positively the function of AC (Marazziti et al. 2013).

5-HT6was first found in NCB-20 cells in 1979 by MacDermont and coworkers, but its...

This is a preview of subscription content, log in to check access.

Notes

Acknowledgment

Author financial support: CAPES (Coordination for the Improvement of Higher Education Personnel).

References

  1. Bruin MNWJ, McCreary AC, van Loevezijn A, de Vries TJ, Venhorst J, Drimmelen M, et al. A novel highly selective 5-HT6 receptor antagonist attenuates ethanol and nicotine seeking but does not affect inhibitory response control in Wistar rats. Behav Brain Res. 2013;236:157–65.  https://doi.org/10.1016/j.bbr.2012.08.048.CrossRefPubMedGoogle Scholar
  2. Codony X, Vela JM, Ramírez MJ. 5-HT6 receptor and cognition. Curr Opin Pharmacol. 2011;11(1):94–100.  https://doi.org/10.1016/j.coph.2011.01.004.CrossRefPubMedGoogle Scholar
  3. Di Chiara G, Valentini V, Fenu S. Behavioral and neurochemical pharmacology of 5-ht6 receptors related to reward and reinforcement. In: Borsini F, editor. International review of neurobiology, Pharmacology of 5-HT6 receptors, part II, vol. 96; 2011. p. 111–39.  https://doi.org/10.1016/B978-0-12-385902-0.00005-X.CrossRefGoogle Scholar
  4. Heal DJ, Smith SL, Fisas A, Codony X, Buschmann H. Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders. Pharmacol Ther. 2008;117(2):207–31.  https://doi.org/10.1016/j.pharmthera.2007.08.006.CrossRefPubMedGoogle Scholar
  5. Helboe L, Egebjerg J, De Jong IEM. Distribution of serotonin receptor 5-HT6 mRNA in rat neuronal subpopulations: a double in situ hybridization study. Neuroscience. 2015;310:442–54.  https://doi.org/10.1016/j.neuroscience.2015.09.064.CrossRefPubMedGoogle Scholar
  6. Hirst WD, Abrahamsen B, Blaney FE, Calver AR, Aloj L, Price GW, et al. Differences in the central nervous system distribution and pharmacology of the mouse 5- hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling. Mol Pharmacol. 2003;64(6):1295–308.  https://doi.org/10.1124/mol.64.6.1295.CrossRefPubMedGoogle Scholar
  7. Karila D, Freret T, Bouet V, Boulouard M, Dallemagne P, Rochais C. Therapeutic potential of 5-HT 6 receptor agonists. J Med Chem. 2015;58(20):7901–12.  https://doi.org/10.1021/acs.jmedchem.5b00179.CrossRefPubMedGoogle Scholar
  8. Knudsen GM, Hasselbalch SG. Imaging of the serotonin system: radiotracers and applications in memory disorders. In: Dierckx RAJO, Otte A, de Vries EFJ, van Waarde A, Luiten PGM, editors. PET and SPECT of neurobiological systems. Berlin/Heidelberg: Springer; 2014. p. 669–86.  https://doi.org/10.1007/978-3-642-42014-6_23.CrossRefGoogle Scholar
  9. Marazziti D, Baroni S, Borsini F, Picchetti M, Vatteroni E, Falaschi V, et al. Serotonin receptors of type 6 (5-HT6): from neuroscience to clinical pharmacology. Curr Med Chem. 2013;20:371–7.  https://doi.org/10.2174/0929867311320030008.CrossRefPubMedGoogle Scholar
  10. Messina D, Annesi G, Serra P, Nicoletti G, Pasqua A, Annesi F, et al. Association of the 5-HT6 receptor gene polymorphism C267T with Parkinson’s disease. Neurology. 2002;58(5):828–9.  https://doi.org/10.1212/WNL.58.5.828.CrossRefPubMedGoogle Scholar
  11. Monsma F, Shen Y, Ward RP, Hamblin MW, Sibley DR. Cloning and expression of a novel serotonin receptor with affinity for tricyclic psychotropic drugs. Mol Pharmacol. 1993;43(3):320–7.PubMedGoogle Scholar
  12. Müller CP, Pum ME, Schumann G, Huston JP. The role of serotonin in drug addiction. In: Müller CP, Jacobs BL, editors. Handbook of behavioral neuroscience, vol. 21; 2010. p. 507–45.  https://doi.org/10.1016/S1569-7339(10)70099-0.CrossRefGoogle Scholar
  13. Pereira M, Martynhak BJ, Andreatini R, Svenningsson P. 5-HT6 receptor agonism facilitates emotional learning. Front Pharmacol. 2015;16(6):200.  https://doi.org/10.3389/fphar.2015.00200.CrossRefGoogle Scholar
  14. Roth BL, Craigo SC, Choudhary MS, Uluer A, Monsma Jr FJ, Shen Y, et al. Binding of typical and atypical antipsychotic agents to 5- hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther. 1994;268(3):1403–10.PubMedGoogle Scholar
  15. Ruat M, Traiffort E, Arrang JM, Tardivel-Lacombe J, Diaz J, Leurs R, et al. A novel rat serotonin (5-HT6) receptor: molecular cloning localization and stimulation of cAMP. Biochem Biophys Res Commun. 1993;193(1):268–76.  https://doi.org/10.1006/bbrc.1993.1619.CrossRefPubMedGoogle Scholar
  16. Schechter LE, Lin Q, Smith DL, Zhang G, Shan Q, Platt B, et al. Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466. Neuropsychopharmacology. 2008;33(6):1323–5.  https://doi.org/10.1038/sj.npp.1301503.CrossRefPubMedGoogle Scholar
  17. Tsai SJ, Liu HC, Liu TY, Wang YC, Hong CJ. Association analysis of the 5-HT6 receptor polymorphism C267T in Alzheimer’s disease. Neurosci Lett. 1999;276(2):138–9.CrossRefPubMedGoogle Scholar
  18. Usworth C, Molinoff P. Characterization of a 5-hyroxytyptamine receptor in mouse neuroblastoma N18TG2 cells. J Pharmacol Exp Ther. 1994;269:245–55.  https://doi.org/10.1016/j.ejphar.2011.03.020.CrossRefGoogle Scholar
  19. Woods S, Clarke NN, Layfield R, Fone KC. 5-HT(6) receptor agonists and antagonists enhance learning and memory in a conditioned emotion response paradigm by modulation of cholinergic and glutamatergic mechanisms. Br J Pharmacol. 2012;167(2):436–49.  https://doi.org/10.1111/j.1476-5381.2012.02022.x.CrossRefPubMedPubMedCentralGoogle Scholar
  20. Woolley ML, Bentley JC, Sleight AJ, Marsden CA, Fone KC. A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze. Neuropharmacology. 2001;41(2):210–9.  https://doi.org/10.1016/S0028-3908(01)00056-9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of Clinical Neuroscience, Center of Molecular Medicine L801Karolinska Institutet - Karolinska University HospitalStockholmSweden